Literature DB >> 17849041

Coagulation factor V and thrombophilia: background and mechanisms.

Kenneth Segers1, Björn Dahlbäck, Gerry A F Nicolaes.   

Abstract

Human coagulation factor V (FV) is an essential coagulation protein with functions in both the pro- and anticoagulant pathways. Failure to express and control FV functions can either lead to bleeding, or to thromboembolic disease. Both events may develop into a life-threatening condition. Since the first description of APC resistance, and in particular the description of the so-called factor V(Leiden) mutation, in which a prominent activated protein C cleavage site in FV has been abolished through a mutation in the FV gene, FV has been in the center of attention of thrombosis research. In this review we describe how the functions of FV are expressed and regulated and provide an extensive description of the role that FV plays in the etiology of thromboembolic disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17849041

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  38 in total

1.  Evaluation of GenoFlow Thrombophilia Array Test Kit in its detection of mutations in Factor V Leiden (G1691A), prothrombin G20210A, MTHFR C677T and A1298C in blood samples from 113 Turkish female patients.

Authors:  Ebru Aytekin; Sezen Guntekin Ergun; Mehmet Ali Ergun; Ferda E Percin
Journal:  Genet Test Mol Biomarkers       Date:  2014-08-25

Review 2.  [Jugular vein thrombosis caused by hypercoagulability following in-vitro fertilization-activated protein C resistance and immobilization].

Authors:  K Stölzel; S Jovanovic; A E Albers
Journal:  HNO       Date:  2013-03       Impact factor: 1.284

3.  The Journey of Protein S from an Anticoagulant to a Signaling Molecule.

Authors:  V S Pilli; William Plautz; Rinku Majumder
Journal:  JSM Biochem Mol Biol       Date:  2016-08-08

4.  Highly active and selective endopeptidases with programmed substrate specificities.

Authors:  Navin Varadarajan; Sarah Rodriguez; Bum-Yeol Hwang; George Georgiou; Brent L Iverson
Journal:  Nat Chem Biol       Date:  2008-05       Impact factor: 15.040

5.  Inflammation-associated activation of coagulation and immune regulation by the protein C pathway.

Authors:  Hartmut Weiler
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

6.  Novel role for galectin-8 protein as mediator of coagulation factor V endocytosis by megakaryocytes.

Authors:  Claudia Zappelli; Carmen van der Zwaan; Daphne C Thijssen-Timmer; Koen Mertens; Alexander B Meijer
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

Review 7.  Triggers, targets and treatments for thrombosis.

Authors:  Nigel Mackman
Journal:  Nature       Date:  2008-02-21       Impact factor: 49.962

8.  Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency.

Authors:  Connie Duckers; Paolo Simioni; Luca Spiezia; Claudia Radu; Sabrina Gavasso; Jan Rosing; Elisabetta Castoldi
Journal:  Blood       Date:  2008-08-11       Impact factor: 22.113

Review 9.  The molecular basis of factor V and VIII procofactor activation.

Authors:  R M Camire; M H A Bos
Journal:  J Thromb Haemost       Date:  2009-09-18       Impact factor: 5.824

10.  [Complication after subacute cervical lymphadenitis].

Authors:  A Knopf; E Q Scherer
Journal:  HNO       Date:  2009-08       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.